Question 1

What is Pentixapharm Holding AG?

Accepted Answer

Pentixapharm Holding AG is a Entity.

Question 2

How often does Pentixapharm Holding AG appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 10 articles.

Question 3

When was Pentixapharm Holding AG first tracked by Ergen?

Accepted Answer

First tracked on Jul 15, 2026.

Question 4

When was Pentixapharm Holding AG last mentioned in news?

Accepted Answer

Last active on Jul 31, 2026.

Question 5

What is Pentixapharm Holding AG's current news sentiment?

Accepted Answer

Aggregate sentiment score: 80 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Pentixapharm Holding AG in global news coverage?

Accepted Answer

Attention score of 2, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Pentixapharm Holding AG?

Accepted Answer

Pentixapharm Phase 3 financing and BUY rating (Jul 15, 2026, 10 articles).

Question 8

How did the "Pentixapharm Phase 3 financing and BUY rating" event impact Pentixapharm Holding AG?

Accepted Answer

Pentixapharm is the subject of the research, receiving a BUY rating and a target price of EUR 7.20. The company completed a EUR 19.7 million rights issuance, strengthening its cash position to fund Phase 3 trials for PentixaFor.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.